Name | Sodium [(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3 ,4-tetrahydrocyclopenta[b]indol-3-yl]acetate |
---|
Description | Laropiprant sodium is a potent and selective DP receptor antagonist with Ki values of 0.57 nM and 2.95 nM for DP receptor and TP Receptor, respectively[1][2][3]. |
---|---|
Related Catalog | |
Target |
TP:2.95 nM (Ki) DP/DP1 Receptor:0.57 nM (Ki) |
In Vitro | Laropiprant sodium (0.01-1000 μM; 10 mins; HEK293 cells) is an Inverse Agonist of DP1 cAMP Signaling and reduces DP1 cAMP signaling below basal levels[1]. Laropiprant sodium (1 μM; 0-24 h; HEK293 cells) is a pharmacochaperone in promoting DP1 cell surface expression[1]. |
References |
Molecular Formula | C21H18ClFNNaO4S |
---|---|
Molecular Weight | 457.87800 |
Exact Mass | 457.05300 |
PSA | 87.58000 |
LogP | 4.13620 |